Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label
tabling member	label

Search

1126459

registered interest
date	14/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cannabis: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what the process will be for patients that are refused a prescription for medical cannabis oil by their second opinion; and will he make a statement.
tabling member constituency	Hemel Hempstead
tabling member printed	Sir Mike Penning
uin	254164
answer	answer is ministerial correction date of answer 21/05/2019 answer text <p>It is right that these decisions are clinically led. As for any other medical treatment, if two clinicians are of the opinion that, on balance, it is not in the best interest of the patient to prescribe a cannabis-based product, then it will not be prescribed.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 21/05/2019 10:45:44 answering member 4455 label Biography information for Seema Kennedy
tabling member	1528 label Biography information for Sir Mike Penning

1126507

registered interest
date	14/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Members: Correspondence
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether he holds information on when the hon. Member for West Lancashire will receive a response to correspondence sent to Lancashire Care Foundation Trust on 14 March 2018 on mental health care.
tabling member constituency	West Lancashire
tabling member printed	Rosie Cooper
uin	254165
answer	answer is ministerial correction date of answer 21/05/2019 answer text <p>NHS Improvement has advised that the Trust responded to the hon. Member’s letter of 14 March 2019 on 17 May 2019.</p> answering member constituency Wimbledon answering member printed Stephen Hammond question first answered 21/05/2019 11:09:33 answering member 1585 label Biography information for Stephen Hammond
tabling member	1538 label Biography information for Rosie Cooper

1126508

registered interest
date	14/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cystic Fibrosis: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what recent progress has been made on making (a) Orkambi and (b) Symkevi available on the NHS for people diagnosed with cystic fibrosis; and if he will make a statement.
tabling member constituency	Tewkesbury
tabling member printed	Mr Laurence Robertson
uin	254113
answer	answer is ministerial correction date of answer 20/05/2019 answer text <p>The National Institute for Health and Care Excellence (NICE) and NHS England are leading the dialogue with Vertex Pharmaceuticals on access to their portfolio of cystic fibrosis medicines, including Orkambi and Symkevi.</p><p>NHS England has proposed an offer that would represent the largest ever commitment of its kind in the history of the National Health Service - in the region of £500 million over five years - and would provide immediate access for patients to all Vertex licensed medicines in advance of assessment by NICE. The Government fully supports the approach that NICE and NHS England are adopting. It is crucial that patients have access to the most effective and innovative medicines at a price that represents value to the NHS.</p><p>My Rt. hon. Friend the Secretary of State for Health and Social Care held a meeting on 11 March with all the parties to discuss how best to reach a deal so that people with cystic fibrosis and their families can benefit as soon as possible. Vertex, NICE and NHS England subsequently met on Thursday 21 March and have agreed to continue discussions.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 20/05/2019 16:00:42 answering member 4455 label Biography information for Seema Kennedy
tabling member	253 label Biography information for Mr Laurence Robertson

1126597

registered interest
date	14/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cataracts: Surgery
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure that cataract removal surgery is available to everyone who would benefit from it.
tabling member constituency	Meriden
tabling member printed	Dame Caroline Spelman
uin	254121
answer	answer is ministerial correction date of answer 21/05/2019 answer text <p>Local clinical commissioning groups (CCGs), with their clinical expertise, are responsible for commissioning high-quality care to meet the needs of their populations. CCGs are required to carefully consider the National Institute for Health and Care Excellence guidelines in making commissioning decisions. These are available at the following link:</p><p><a href="https://www.nice.org.uk/guidance/ng77" target="_blank">https://www.nice.org.uk/guidance/ng77</a></p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 21/05/2019 10:44:28 answering member 4455 label Biography information for Seema Kennedy
tabling member	312 label Biography information for Dame Caroline Spelman

1126621

registered interest
date	14/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Mental Health
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what mental health support are NHS trusts required to make available to staff employed on neonatal intensive care units.
tabling member constituency	Lewisham, Deptford
tabling member printed	Vicky Foxcroft
uin	254230
answer	answer is ministerial correction date of answer 21/05/2019 answer text <p>National Health Service trusts are responsible for ensuring that appropriate mental health support and provision is in place for all of their staff, including those on neonatal intensive care units. Mental health support services provided by trusts could include access to occupational health services, employee assistance programmes, confidential counselling helplines, processes for open sharing of experiences, crisis and trauma response provision and team and peer support structures.</p><p>The Department is supporting them in this through the NHS staff health and wellbeing framework and NHS Improvement’s NHS staff health and wellbeing collaborative. Both incorporate the mental health standards in ‘Thriving at Work – a review of mental health and employers’ produced by Mind.</p> answering member constituency Wimbledon answering member printed Stephen Hammond question first answered 21/05/2019 11:11:35 answering member 1585 label Biography information for Stephen Hammond
tabling member	4491 label Biography information for Vicky Foxcroft

1126655

registered interest
date	14/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Opioids: Prescriptions
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 9 May 2019 to Question 250763 on Opiates: Prescriptions, if he will make it his policy to include direct hyperlinks to reports or materials referenced in written answers to hon. Members.
tabling member constituency	Vale of Clwyd
tabling member printed	Chris Ruane
uin	254155
answer	answer is ministerial correction date of answer 20/05/2019 answer text <p>Further to the answer to Question 250763, the Care Quality Commission’s controlled drugs annual reports are available at the following links:</p><p> </p><p>‘The safer management of controlled drugs: Annual update 2017’ (published July 2018).</p><p><a href="https://www.cqc.org.uk/sites/default/files/20180718_controlleddrugs2017_report.pdf" target="_blank">https://www.cqc.org.uk/sites/default/files/20180718_controlleddrugs2017_report.pdf</a></p><p> </p><p>‘The safer management of controlled drugs: Annual update 2016’ (published July 2017).</p><p><a href="https://www.cqc.org.uk/sites/default/files/20170718_controlleddrugs2016_report.pdf" target="_blank">https://www.cqc.org.uk/sites/default/files/20170718_controlleddrugs2016_report.pdf</a></p><p> </p><p>‘The safer management of controlled drugs: Annual report 2015’ (published July 2016).</p><p><a href="https://www.cqc.org.uk/sites/default/files/20160714_controlleddrugs2015_report.pdf" target="_blank">https://www.cqc.org.uk/sites/default/files/20160714_controlleddrugs2015_report.pdf</a></p><p> </p><p>‘The safer management of controlled drugs: Annual report 2014’ (published July 2015).</p><p><a href="https://www.cqc.org.uk/sites/default/files/20150716_safer_management_controlled_drugs_annual_report_2014.pdf" target="_blank">https://www.cqc.org.uk/sites/default/files/20150716_safer_management_controlled_drugs_annual_report_2014.pdf</a></p><p> </p><p>‘The safer management of controlled drugs: Annual report 2013’ (published August 2014).</p><p><a href="https://www.cqc.org.uk/sites/default/files/20140811%20CQC%20Controlled%20drugs%20annual%20report%202013%20final.pdf" target="_blank">https://www.cqc.org.uk/sites/default/files/20140811%20CQC%20Controlled%20drugs%20annual%20report%202013%20final.pdf</a></p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 20/05/2019 13:38:52 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	534 label Biography information for Chris Ruane

1126677

registered interest
date	14/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Pregnancy
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to the paper entitled, Continuation of Unintended Pregnancy published by the Catholic Medical Association in March 2019, what plans his Department has to develop and improve support for mothers who wish to continue with a pregnancy.
tabling member constituency	Congleton
tabling member printed	Fiona Bruce
uin	254178
answer	answer is ministerial correction date of answer 20/05/2019 answer text <p>Women who access healthcare services when pregnant have consultations and conversations with their health care professionals covering their clinical and social history and will be offered tailored advice and support. Care and advice is available to all pregnant women, including those for whom the pregnancy was unintended.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 20/05/2019 14:19:08 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	3958 label Biography information for Fiona Bruce

1126678

registered interest
date	14/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Prescriptions: Universal Credit
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what the timeframe is for NHS prescription forms to be amended to include tick boxes for universal credit.
tabling member constituency	Birkenhead
tabling member printed	Frank Field
uin	254153
answer	answer is ministerial correction date of answer 20/05/2019 answer text <p>A revised version of the FP10 prescription form, featuring a dedicated tick-box for use by Universal Credit claimants who meet the criteria for free National Health Service prescriptions, recently received Ministerial clearance.</p><p> </p><p>Any change involves major system and software updates across the NHS to allow the re-designed form to be used and processed. The revised paper form is currently being prepared for testing, to ensure it is compatible with the scanners used by the NHS Business Services Authority.</p><p> </p><p>The revised form will be introduced at the earliest opportunity.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 20/05/2019 15:59:00 answering member 4455 label Biography information for Seema Kennedy
tabling member	478 label Biography information for Lord Field of Birkenhead

1126002

registered interest
date	13/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cancer
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the effect of medical nutrition on clinical outcomes for cancer patients.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	253575
answer	answer is ministerial correction date of answer 21/05/2019 answer text <p>The National Institute for Health and Care Excellence (NICE) guidance on ‘Oesophago-gastric cancer: assessment and management in adults’ (2018) cautions that while nutrition support can improve surgical outcomes, practice in this field varies nationally so its effectiveness has not been determined.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 21/05/2019 10:53:13 answering member 4455 label Biography information for Seema Kennedy
tabling member	4131 label Biography information for Jim Shannon

1126022

registered interest
date	13/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	National Institute for Health and Care Excellence
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will expedite the process by which the NICE publishes its decisions.
tabling member constituency	Stroud
tabling member printed	Dr David Drew
uin	253483
answer	answer is ministerial correction date of answer 21/05/2019 answer text <p>The Government wants patients to be able to benefit from access to effective new treatments as quickly as possible.</p><p>Through its technology appraisal and highly specialised technologies guidance, the National Institute for Health and Care Excellence (NICE) makes authoritative, evidence-based recommendations on whether medicines and other treatments represent a clinically and cost effective use of National Health Service resources. NHS organisations are legally required to make funding available for NICE recommended treatments, usually within three months of final guidance.</p><p>Wherever possible, NICE currently aims to publish recommendations on new drugs as soon as possible after licensing, with draft guidance on cancer drugs published in advance of licensing. The 2019 Voluntary Scheme for Branded Medicines Pricing and Access includes a commitment to faster NICE assessments of new medicines, with timelines for non-cancer drugs to match those for cancer drugs, subject to the evidence base for the product being sufficiently developed.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 21/05/2019 10:58:38 answering member 4455 label Biography information for Seema Kennedy
tabling member	252 label Biography information for Dr David Drew